Skip to main content
. 2022 Feb 7;33:102956. doi: 10.1016/j.nicl.2022.102956

Table 1.

Subject characteristics.

Age (yrs) Sex ASM (%) ASM Duration Seizure Free (median and range)
Control 8.9–14.9 3M/5F N/A N/A N/A
Active 9–14.7 5M/3F 50% Levetiracetam (2), Lamotrigine (1),
and Lacosamide (1)
54 days (10 days – 1 year)
Resolve 10.3–16.7 9M/1F 60% Levetiracetam (5) 2.2 years (1.2 – 4.3 years)

P-value 0.25 0.07†† 1††

ASM = antiseizure medication during EEG recording. One-way ANOVA. ††Fisher’s exact test.